Boston Scientific Corporation Securities Litigation (2019)

If you purchased a significant amount of shares of Boston Scientific Corporation (NYSE: BSX), you have certain options. Investors should register for updates.


Lawsuit Overview

Defendant:Boston Scientific Corporation
Date Filed:April 24th, 2019
Sector:Health Care
Industry:Medical/Dental Instruments

According to the Complaint, Boston Scientific Corporation y develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Boston Scientific's surgical mesh products indicated for the transvaginal repair of POP were unsafe; (ii) accordingly, Boston Scientific's continued marketing and sales of these devices in the United States was unlikely to be sustainable; (iii) separately, the Company had sold vaginal mesh implants containing counterfeit or adulterated resin products imported from China; (iv) the foregoing conduct subjected the Company to a heightened risk of regulatory scrutiny and/or government investigations; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Boston Scientific Corporation

First Identified Complaint

Steve Klein, et al. v. Boston Scientific Corporation, et al.

Date Filed:April 24th, 2019
Class Period Start:February 26th, 2015
Class Period End:April 16th, 2019
First Identified Complaint Filings
#Document TitleFiling Date